Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR known ✓ | P00533 | 7/20 | 0.52 |
| ▸ | SRC known ✓ | P12931 | 1/20 | 0.43 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.42 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | UBE2N | P61088 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8781890 | 0.98 | EGFR (0.51) | EGFRALDH1A1UBE2NMAPTHPGD | |
| Ammonia Solution, Strong SCHEMBL28520484 | 0.97 | EGFR (0.50) | EGFRALDH1A1UBE2NMAPTHPGD | |
| Hydrochloric Acid SCHEMBL5708087 | 0.92 | LTA4H (0.49) | EGFRALDH1A1UBE2NMAPTHPGD | |
| Acrylamide SCHEMBL5201626 | 0.91 | EGFR (0.45) | EGFRALDH1A1UBE2NMAPTHPGD | |
| Hydrochloric Acid SCHEMBL14336096 | 0.85 | EGFR (0.41) | EGFRALDH1A1UBE2NMAPTHPGD | |
| SCHEMBL27568705 | 0.84 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1KMT2ACHRM1LMNA | |
| SCHEMBL601114 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL21880499 | 0.81 | L3MBTL1 (0.45) | EGFRALDH1A1MAPTHPGDL3MBTL1 | |
| Hydrochloric Acid SCHEMBL28343485 | 0.81 | EGFR (0.51) | EGFRALDH1A1UBE2NMAPTHPGD | |
| SCHEMBL26424203 | 0.80 | ALDH1A1 (0.56) | ALDH1A1MAPTHPGDMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2720668-B1 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | OREAL (FR) | 2020-05-06 | — | — | EP | claimed |
| EP-2720668-A2 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | L'Oréal (FR) | 2014-04-23 | — | — | EP | claimed |
| WO-2012175330-A2 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | L'OREAL (FR) | 2012-12-27 | — | — | WO | claimed |
| US-20070248551-A1 | Use as an Antiperspirant Agent of a Flocculating Water-Soluble Polymer; Cosmetic Process for Treating Perspiration | L'OREAL S.A. (FR) | 2007-10-25 | — | — | US | claimed |
| EP-1761241-A1 | USE AS AN ANTIPERSPIRANT AGENT OF A FLOCCULATING WATER-SOLUBLE POLYMER; COSMETIC PROCESS FOR TREATING PERSPIRATION | l'Oreal SA (FR) | 2007-03-14 | — | — | EP | claimed |
| WO-2005120448-A1 | USE AS AN ANTIPERSPIRANT AGENT OF A FLOCCULATING WATER-SOLUBLE POLYMER; COSMETIC PROCESS FOR TREATING PERSPIRATION | L'OREAL (FR) | 2005-12-22 | — | — | WO | claimed |
| CN-114656831-A | Ink set and ink jet recording method | 精工爱普生株式会社 | 2022-06-24 | — | — | CN | disclosed |
| EP-2720668-B1 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | OREAL (FR) | 2020-05-06 | — | — | EP | disclosed |
| EP-2720668-A2 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | L'Oréal (FR) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012175330-A2 | COSMETIC USE OF A FLOCCULANT POLYMER AS ANTIPERSPIRANT | L'OREAL (FR) | 2012-12-27 | — | — | WO | disclosed |
| US-20070248551-A1 | Use as an Antiperspirant Agent of a Flocculating Water-Soluble Polymer; Cosmetic Process for Treating Perspiration | L'OREAL S.A. (FR) | 2007-10-25 | — | — | US | disclosed |
| EP-1761241-A1 | USE AS AN ANTIPERSPIRANT AGENT OF A FLOCCULATING WATER-SOLUBLE POLYMER; COSMETIC PROCESS FOR TREATING PERSPIRATION | l'Oreal SA (FR) | 2007-03-14 | — | — | EP | disclosed |
| EP-1394207-B1 | DISPERSION COMPOSITION AND INK-JET PRINTER INK COMPRISING THE SAME | HITACHI MAXELL (JP) | 2006-11-22 | — | — | EP | disclosed |
| US-7029110-B2 | Dispersion composition and ink-jet printer ink comprising the same | HITACHI MAXELL, LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| WO-2005120448-A1 | USE AS AN ANTIPERSPIRANT AGENT OF A FLOCCULATING WATER-SOLUBLE POLYMER; COSMETIC PROCESS FOR TREATING PERSPIRATION | L'OREAL (FR) | 2005-12-22 | — | — | WO | disclosed |
| US-20040116552-A1 | Dispersion composition and ink-jet printer ink comprising the same | HITACHI MAXELL, LTD. (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1394207-A1 | DISPERSION COMPOSITION AND INK-JET PRINTER INK COMPRISING THE SAME | HITACHI MAXELL, LTD. (JP) | 2004-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070248551-A1 | Use as an Antiperspirant Agent of a Flocculating Water-Soluble Polymer; Cosmetic Process for Treating Perspiration | CUTA, TYR, PRKDC | EGFR 616/4885SRC 1582/4885SLC6A2 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.